Half-Life Cancer Research Results

Half-Life, Half-Life: Click to Expand ⟱

Source:

Type:

For many drugs, the half-life is the time it takes for half of the drug’s active substance to be eliminated from the bloodstream.
In medicine, knowing a drug’s half-life helps in designing treatment regimens that reduce adverse effects.

GBM, Glioblastoma: Click to Expand ⟱

Glioblastoma is a fast-growing and aggressive brain tumor.

Scientific Papers found: Click to Expand⟱

6024-

CGA,

Phase I study of chlorogenic acid injection for recurrent high-grade glioma with long-term follow-up

Trial,

GBM,

26 eligible patients were enrolled, received intramuscular CGA injections at 5 dose levels, and were followed up for 5 years.

*toxicity↓, Half-Life↝, BBB↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:

Barriers & Transport ⓘ

BBB↑, 1,

Drug Metabolism & Resistance ⓘ

Half-Life↝, 1,
Total Targets: 2

Pathway results for Effect on Normal Cells:

Functional Outcomes ⓘ

toxicity↓, 1,
Total Targets: 1

Scientific Paper Hit Count for: Half-Life, Half-Life

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells